PfizerItem # 116301MPN 01163-01

Bupivacaine 0.5% 250 mg/50 mL 5 mg/mL 50 mL MDV, 25/Bx

In StockPrescription required

This item is prescription-controlled. A valid medical license must be on file for your account before it can be ordered.

Bupivacaine 0.5% Hydrochloride Injection, USP

Multiple Dose Glass Fliptop Vial (Solution) 50 mL

Local anesthetics block the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential.

NDC unit of Use: 0409-1163-18

NDC unit of Sale: 0409-1163-01

Concentration 5 mg/mL

Content: 250 mg/50 mL Multi-Dose Vial

25 vials per pack

Non-DEHP

Manufacturer: Pfizer
Sold By: Case of 25

How does Bupivacaine 0.5% differ from other local anesthetics available on the market?

Bupivacaine 0.5% is designed to block nerve impulses by increasing the threshold for electrical excitation, slowing the propagation of the impulse, and reducing the rate of rise of the action potential, which may offer a different efficacy or duration of anesthesia compared to other local anesthetics [Manufacturer Info].

What precautions should be taken when administering Bupivacaine 0.5% to patients with a known allergy to anesthetics?

When administering Bupivacaine 0.5% to patients with anesthetic allergies, clinicians should review patient history for hypersensitivity to amide-type local anesthetics, monitor closely for signs of allergic reactions, and have emergency resuscitative equipment readily available [Manufacturer Info].

Can this product be safely used for outpatient surgeries that involve prolonged anesthesia?

Bupivacaine 0.5% is typically suitable for procedures requiring prolonged anesthesia due to its ability to slow nerve impulse propagation and extend the duration of action, making it a potential option for outpatient surgeries, subject to individual patient assessment [Manufacturer Info].

How does the multi-dose glass vial design impact its usage in a fast-paced clinical setting?

The multi-dose glass vial design of Bupivacaine 0.5% supports efficient usage in fast-paced clinical settings by allowing multiple doses to be administered from a single vial, reducing waste and enhancing the speed of preparation [Product Specs].

What should clinicians watch for during administration to prevent potential side effects?

Clinicians should monitor for potential side effects such as cardiovascular and central nervous system complications, and ensure proper dosing and adherence to recommended administration techniques to minimize risks [Manufacturer Info].

Bupivacaine 0.5% 250 mg/50 mL 5 mg/mL 50 mL MDV, 25/Bx

Bupivacaine 0.5% 250 mg/50 mL 5 mg/mL 50 mL MDV, 25/Bx

Bupivacaine 0.5% 250 mg/50 mL 5 mg/mL 50 mL MDV, 25/Bx

Frequently bought together

Hypodermic Needle 25G x 1½", 100/Bx

Lidocaine 2% 1,000 mg/50 mL 20 mg/mL 50 mL MDV, 10/Bx

Lidocaine 2% 1,000 mg/50 mL 20 mg/mL 50 mL MDV, 25/Bx

Lidocaine 1% 500 mg/50 mL 10 mg/mL 50 mL MDV, 25/Bx

Bupivacaine 0.5% 250 mg/50 mL 5 mg/mL 50 mL MDV, 25/Bx

Frequently bought together

Hypodermic Needle 25G x 1½", 100/Bx

Lidocaine 2% 1,000 mg/50 mL 20 mg/mL 50 mL MDV, 10/Bx

Lidocaine 2% 1,000 mg/50 mL 20 mg/mL 50 mL MDV, 25/Bx

Lidocaine 1% 500 mg/50 mL 10 mg/mL 50 mL MDV, 25/Bx

Frequently bought together

Hypodermic Needle 25G x 1½", 100/Bx

Lidocaine 2% 1,000 mg/50 mL 20 mg/mL 50 mL MDV, 10/Bx

Lidocaine 2% 1,000 mg/50 mL 20 mg/mL 50 mL MDV, 25/Bx

Lidocaine 1% 500 mg/50 mL 10 mg/mL 50 mL MDV, 25/Bx

Frequently bought together

Hypodermic Needle 25G x 1½", 100/Bx

Lidocaine 2% 1,000 mg/50 mL 20 mg/mL 50 mL MDV, 10/Bx

Lidocaine 2% 1,000 mg/50 mL 20 mg/mL 50 mL MDV, 25/Bx

Lidocaine 1% 500 mg/50 mL 10 mg/mL 50 mL MDV, 25/Bx